PT  - JOURNAL ARTICLE
AU  - Julian De Freitas
AU  - Brian A. Falls
AU  - Omar S. Haque
AU  - Harold J. Bursztajn
TI  - Recognizing Misleading Pharmaceutical Marketing Online
DP  - 2014 Jun 01
TA  - Journal of the American Academy of Psychiatry and the Law Online
PG  - 219--225
VI  - 42
IP  - 2
4099  - http://jaapl.org/content/42/2/219.short
4100  - http://jaapl.org/content/42/2/219.full
SO  - J Am Acad Psychiatry Law2014 Jun 01; 42
AB  - In light of decision-making psychology, this article details how drug marketing operates across established and novel web domains and identifies some common misleading trends and influences on prescribing and patient-initiated medication requests. The Internet has allowed pharmaceutical marketing to become more salient than ever before. Although the Internet's growth has improved the dissemination of pharmaceutical information, it has also led to the increased influence of misleading pharmaceutical marketing. Such mismarketing is of concern, especially in psychiatry, since psychotropics generate considerable revenue for drug companies. In a climate of resource-limited drug regulation and time-strapped physicians, we recommend improving both independent monitoring and consumer awareness of Internet-enabled, potentially misleading, pharmaceutical marketing influences.